| Neutropenia |
1 |
0.87 |
| Leukopenia |
0 |
0.76 |
| Blood Dyscrasia |
0 |
0.43 |
| Blood |
0 |
0.35 |
| Borderline Personality Disorder |
0 |
0.32 |
| Complete Blood Count |
0 |
0.29 |
| White Blood Cell Count |
0 |
0.29 |
| Thrombocytopenia |
0 |
0.28 |
| Myelosuppression |
0 |
0.18 |
| Opioids |
0 |
0.15 |
| Platelet Count |
0 |
0.15 |
| Addiction |
0 |
0.14 |
| Bone Marrow |
0 |
0.14 |
| Food and Drug Administration (FDA) |
0 |
0.14 |
| Post-Traumatic Stress Disorder |
0 |
0.12 |
| Epilepsy |
0 |
0.11 |
| Bone |
0 |
0.1 |
| Mood Disorders |
0 |
0.1 |
| Neutrophils |
0 |
0.1 |
| Patient History |
0 |
0.1 |
| Personality Disorders |
0 |
0.1 |
| Psychotropic Drugs |
0 |
0.1 |
| Stimulants |
0 |
0.1 |
| Methamphetamine |
0 |
0.09 |
| Toxicology |
0 |
0.09 |
| Cardiometabolic Risk Factors |
0 |
0.08 |
| Bipolar Disorder |
0 |
0.07 |
| Pulmonary Nodule |
0 |
0.07 |
| Lipids Management |
0 |
0.06 |
| Type 2 Diabetes Mellitus |
0 |
0.06 |
| Adherence |
0 |
0.05 |
| Adverse Effects |
0 |
0.05 |
| Alcohol Use |
0 |
0.05 |
| Antipsychotics |
0 |
0.05 |
| Behavioral Modification Therapy |
0 |
0.05 |
| Child |
0 |
0.05 |
| Drug Reaction |
0 |
0.05 |
| Hyperlipidemia |
0 |
0.05 |
| Insomnia |
0 |
0.05 |
| Nodule |
0 |
0.05 |
| Outpatient Clinic |
0 |
0.05 |
| Polypharmacy |
0 |
0.05 |
| Prediabetes |
0 |
0.05 |
| Prophylaxis |
0 |
0.05 |
| Sedative |
0 |
0.05 |
| Seizure |
0 |
0.05 |
| Stress |
0 |
0.05 |
| Health Care Reform |
0 |
0.04 |
| Hypertension |
0 |
0.04 |
| Migraine |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Sleep Disorders |
0 |
0.04 |